Skip to Content


Akadeum’s History of Introducing Innovative New Products at ASGCT Continues

Published on May 7, 2024

Akadeum, the sole proprietor of ground-breaking microbubble technology, is expanding its market-leading product portfolio by announcing transformative new products at ASGCT. ANN ARBOR, MI, May 7, 2024 – Akadeum Life Sciences, the industry leader in buoyancy-based cell separation, is announcing a number of innovative new products at the American Society of Gene & Cell Therapy’s 27th Annual Meeting in Baltimore, Maryland, today. The unparalleled speed of Akadeum’s product development has …

Akadeum at the ASGCT 27th Annual Meeting in Baltimore

Published on Mar 28, 2024

ASGCT 2024 Logo

We are excited to announce that Akadeum Life Sciences will attend the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting in Baltimore from May 7-11, 2024. The highlight of the gene and cell therapy calendar, this conference brings together the brightest minds in academia and industry to share the latest scientific research and stay up to date with cutting-edge technologies. As part of our commitment to advancing …

Akadeum Collaboration With Agilent Brings Microbubbles to Wastewater Testing

Published on Mar 8, 2024

Akadeum Life Sciences has joined forces with Agilent to combat the spread of infectious diseases through innovative wastewater testing kits. Highlighted in a recent Patient Safety & Quality Healthcare publication, this collaboration will revolutionize public health surveillance, providing a faster, simpler, and more efficient alternative to traditional methods when extracting important diagnostic markers from wastewater samples. The new Viral DNA-RNA Wastewater Prep Kit leverages microbubbles to extract nucleic acids gently …

Akadeum Life Sciences Appoints Jeff Williams and Brett Williams to Their Board of Directors

Published on Feb 14, 2024

The additions of Jeff Williams and Brett Williams will reinforce Akadeum’s strategic expansion and drive commercial growth in the cell separation and life sciences industry. Ann Arbor, MI, February 14, 2024 – Akadeum Life Sciences, the global leader in buoyancy-based cell separation, has today announced the appointment of Jeff Williams as Executive Chairman of the board and Brett Williams as a Director of the board. Jeff and Brett will play …

Akadeum Awarded Top 10 BioTech Startups of 2023 by PharmaTech Outlook

Published on Feb 13, 2024

“Our dedication to thorough research and our commitment to listening to the voice of the customer has resulted in a truly outstanding innovation.” Akadeum Life Sciences was recently featured as a Top 10 BioTech Startup of 2023 by PharmaTech Outlook magazine. In recognition of the award, PharmaTech Outlook published an article highlighting the innovative work happening at Akadeum to reignite the stagnant cell separation market. Akadeum’s microbubble technology overcomes the …

Akadeum Life Sciences Announces Two New Microbubble Kits at Advanced Therapies Week

Published on Jan 17, 2024

The Human T Cell Selection, Activation, and Expansion and Human T Cell Depletion kits use Akadeum’s BACS™ microbubbles to streamline cell therapy workflows. ANN ARBOR, MI, Jan 16, 2024 – Today, Akadeum Life Sciences, the market leader in buoyancy-based cell separation is announcing the release of a Human T Cell Selection, Activation, and Expansion Kit (GMP Grade), and a Human T Cell Depletion Kit (GMP Grade) at the Advanced Therapies …

Akadeum Life Sciences and Agilent Technologies Announce Viral DNA/RNA Wastewater Surveillance Solution

Published on Jan 9, 2024

Partnership uses Akadeum’s revolutionary microbubble technology for viral processing. ANN ARBOR, Michigan, Jan. 5, 2024 – Akadeum Life Sciences, Inc., announced today an innovative solution for the detection of viral DNA/RNA in wastewater, developed from a collaboration with Agilent Technologies, Inc. which started in October 2019. Wastewater surveillance monitoring has become an important method for mass screening of communities, offering an early warning system for emerging infectious diseases like SARS-CoV-2. …

Akadeum to Present on Award-Winning Microbubble Platform at Biotech Showcase 2024

Published on Jan 8, 2024

With products that gently isolate and activate cells, Akadeum’s founder and CEO will discuss the impact the company is having on the cell and gene therapy space. ANN ARBOR, MI, Jan. 8, 2024 – Akadeum Life Sciences—the global leader in buoyancy-based cell separation technology—has been selected to present on its revolutionary microbubble platform at this year’s Biotech Showcase, which is being held from January 8-10 in San Francisco. Brandon McNaughton, …

Akadeum CEO’s Interview With BioWorld: Alerion System to Transform Cell Therapy

Published on Jan 3, 2024

Alerion™ Device Logo

Brandon McNaughton, CEO of Akadeum Life Sciences Inc., recently shared insights with BioWorld about the company’s Alerion™ Microbubble Cell Separation System, set to transform cell therapy. Akadeum, established in 2014, has developed a unique microbubble-based cell separation technology. The Alerion™ Microbubble Cell Separation System promises to overcome the limitations of existing methods, offering better workflows, scalability, and productivity. The Alerion™ system uses a two-chamber consumable, allowing microbubbles to adhere to …

Microbubbles Offer Accessible and Effective Cancer Treatments

Published on Jan 2, 2024

Cancer Treatment Concept With Microbubbles

Akadeum Life Sciences CEO and Co-Founder Brandon McNaughton‘s recent article, “Microbubbles: The Unlikely Key to Providing Accessible and Effective Cancer Treatments,” has been published by Onco’Zine. Onco’Zine informs and supports healthcare professionals, academics, and pharmaceutical experts in oncology, covering the latest research and developments in the field. McNaughton discusses how Akadeum’s microbubble technology can revolutionize T cell isolation, reducing costs and improving the efficacy of cell therapies like CAR T …

Back to Top